nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—Abdominal pain upper—Entecavir—hepatitis B	0.0196	0.0204	CcSEcCtD
Loratadine—Abdominal pain upper—Telbivudine—hepatitis B	0.0161	0.0167	CcSEcCtD
Loratadine—Hepatobiliary disease—Entecavir—hepatitis B	0.0156	0.0162	CcSEcCtD
Loratadine—Gastritis—Telbivudine—hepatitis B	0.0156	0.0162	CcSEcCtD
Loratadine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.0152	0.0159	CcSEcCtD
Loratadine—Viral infection—Lamivudine—hepatitis B	0.0151	0.0157	CcSEcCtD
Loratadine—Drug interaction—Lamivudine—hepatitis B	0.0147	0.0153	CcSEcCtD
Loratadine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.0143	0.0149	CcSEcCtD
Loratadine—Immune system disorder—Entecavir—hepatitis B	0.0134	0.0139	CcSEcCtD
Loratadine—Alopecia—Entecavir—hepatitis B	0.0131	0.0136	CcSEcCtD
Loratadine—Hepatobiliary disease—Telbivudine—hepatitis B	0.0128	0.0133	CcSEcCtD
Loratadine—Pharyngitis—Telbivudine—hepatitis B	0.0121	0.0126	CcSEcCtD
Loratadine—Cough—Adefovir Dipivoxil—hepatitis B	0.011	0.0114	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.0109	0.0113	CcSEcCtD
Loratadine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.0107	0.0112	CcSEcCtD
Loratadine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.0107	0.0112	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0106	0.0111	CcSEcCtD
Loratadine—Anaphylactic shock—Entecavir—hepatitis B	0.0105	0.011	CcSEcCtD
Loratadine—Dysgeusia—Telbivudine—hepatitis B	0.0104	0.0108	CcSEcCtD
Loratadine—Nervous system disorder—Entecavir—hepatitis B	0.0103	0.0107	CcSEcCtD
Loratadine—Skin disorder—Entecavir—hepatitis B	0.0102	0.0106	CcSEcCtD
Loratadine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0101	0.0105	CcSEcCtD
Loratadine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00997	0.0104	CcSEcCtD
Loratadine—Ill-defined disorder—Telbivudine—hepatitis B	0.00983	0.0102	CcSEcCtD
Loratadine—Malaise—Telbivudine—hepatitis B	0.00955	0.00994	CcSEcCtD
Loratadine—Insomnia—Entecavir—hepatitis B	0.00952	0.00991	CcSEcCtD
Loratadine—Somnolence—Entecavir—hepatitis B	0.00936	0.00974	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00935	0.00974	CcSEcCtD
Loratadine—Dyspepsia—Entecavir—hepatitis B	0.00926	0.00964	CcSEcCtD
Loratadine—Cough—Telbivudine—hepatitis B	0.00924	0.00962	CcSEcCtD
Loratadine—Gastrointestinal disorder—Entecavir—hepatitis B	0.00909	0.00946	CcSEcCtD
Loratadine—Fatigue—Entecavir—hepatitis B	0.00907	0.00945	CcSEcCtD
Loratadine—Abdominal pain upper—Lamivudine—hepatitis B	0.00905	0.00943	CcSEcCtD
Loratadine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00904	0.00941	CcSEcCtD
Loratadine—Myalgia—Telbivudine—hepatitis B	0.00902	0.00939	CcSEcCtD
Loratadine—Chest pain—Telbivudine—hepatitis B	0.00902	0.00939	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00896	0.00932	CcSEcCtD
Loratadine—Discomfort—Telbivudine—hepatitis B	0.00891	0.00928	CcSEcCtD
Loratadine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00886	0.00923	CcSEcCtD
Loratadine—Gastrointestinal pain—Entecavir—hepatitis B	0.00861	0.00896	CcSEcCtD
Loratadine—Nervous system disorder—Telbivudine—hepatitis B	0.00848	0.00883	CcSEcCtD
Loratadine—Skin disorder—Telbivudine—hepatitis B	0.0084	0.00874	CcSEcCtD
Loratadine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.0084	0.00874	CcSEcCtD
Loratadine—Body temperature increased—Entecavir—hepatitis B	0.00832	0.00866	CcSEcCtD
Loratadine—Abdominal pain—Entecavir—hepatitis B	0.00832	0.00866	CcSEcCtD
Loratadine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00812	0.00845	CcSEcCtD
Loratadine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00812	0.00845	CcSEcCtD
Loratadine—Pollakiuria—Lamivudine—hepatitis B	0.00791	0.00824	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00788	0.0082	CcSEcCtD
Loratadine—Insomnia—Telbivudine—hepatitis B	0.00782	0.00814	CcSEcCtD
Loratadine—Paraesthesia—Telbivudine—hepatitis B	0.00776	0.00808	CcSEcCtD
Loratadine—Depression—Lamivudine—hepatitis B	0.00762	0.00793	CcSEcCtD
Loratadine—Dyspepsia—Telbivudine—hepatitis B	0.00761	0.00792	CcSEcCtD
Loratadine—Asthenia—Entecavir—hepatitis B	0.00755	0.00786	CcSEcCtD
Loratadine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00746	0.00777	CcSEcCtD
Loratadine—Fatigue—Telbivudine—hepatitis B	0.00745	0.00776	CcSEcCtD
Loratadine—Pain—Telbivudine—hepatitis B	0.00739	0.0077	CcSEcCtD
Loratadine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00737	0.00767	CcSEcCtD
Loratadine—Hepatobiliary disease—Lamivudine—hepatitis B	0.00722	0.00752	CcSEcCtD
Loratadine—Epistaxis—Lamivudine—hepatitis B	0.00721	0.0075	CcSEcCtD
Loratadine—Diarrhoea—Entecavir—hepatitis B	0.0072	0.0075	CcSEcCtD
Loratadine—Feeling abnormal—Telbivudine—hepatitis B	0.00712	0.00742	CcSEcCtD
Loratadine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00707	0.00736	CcSEcCtD
Loratadine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00703	0.00731	CcSEcCtD
Loratadine—Dizziness—Entecavir—hepatitis B	0.00696	0.00724	CcSEcCtD
Loratadine—Abdominal pain—Telbivudine—hepatitis B	0.00683	0.00711	CcSEcCtD
Loratadine—Body temperature increased—Telbivudine—hepatitis B	0.00683	0.00711	CcSEcCtD
Loratadine—Pharyngitis—Lamivudine—hepatitis B	0.00681	0.00709	CcSEcCtD
Loratadine—Vomiting—Entecavir—hepatitis B	0.00669	0.00697	CcSEcCtD
Loratadine—Rash—Entecavir—hepatitis B	0.00664	0.00691	CcSEcCtD
Loratadine—Dermatitis—Entecavir—hepatitis B	0.00663	0.0069	CcSEcCtD
Loratadine—Headache—Entecavir—hepatitis B	0.00659	0.00686	CcSEcCtD
Loratadine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00653	0.0068	CcSEcCtD
Loratadine—Rash—Adefovir Dipivoxil—hepatitis B	0.00647	0.00674	CcSEcCtD
Loratadine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00647	0.00673	CcSEcCtD
Loratadine—Headache—Adefovir Dipivoxil—hepatitis B	0.00643	0.0067	CcSEcCtD
Loratadine—Nausea—Entecavir—hepatitis B	0.00625	0.00651	CcSEcCtD
Loratadine—Asthenia—Telbivudine—hepatitis B	0.0062	0.00646	CcSEcCtD
Loratadine—Immune system disorder—Lamivudine—hepatitis B	0.00619	0.00645	CcSEcCtD
Loratadine—Nausea—Adefovir Dipivoxil—hepatitis B	0.0061	0.00635	CcSEcCtD
Loratadine—Alopecia—Lamivudine—hepatitis B	0.00606	0.00631	CcSEcCtD
Loratadine—Diarrhoea—Telbivudine—hepatitis B	0.00592	0.00616	CcSEcCtD
Loratadine—Tension—Lamivudine—hepatitis B	0.00586	0.0061	CcSEcCtD
Loratadine—Dysgeusia—Lamivudine—hepatitis B	0.00585	0.00609	CcSEcCtD
Loratadine—Nervousness—Lamivudine—hepatitis B	0.0058	0.00604	CcSEcCtD
Loratadine—Dizziness—Telbivudine—hepatitis B	0.00572	0.00595	CcSEcCtD
Loratadine—Ill-defined disorder—Lamivudine—hepatitis B	0.00554	0.00577	CcSEcCtD
Loratadine—Vomiting—Telbivudine—hepatitis B	0.0055	0.00572	CcSEcCtD
Loratadine—Angioedema—Lamivudine—hepatitis B	0.00545	0.00568	CcSEcCtD
Loratadine—Rash—Telbivudine—hepatitis B	0.00545	0.00567	CcSEcCtD
Loratadine—Dermatitis—Telbivudine—hepatitis B	0.00545	0.00567	CcSEcCtD
Loratadine—Headache—Telbivudine—hepatitis B	0.00542	0.00564	CcSEcCtD
Loratadine—Malaise—Lamivudine—hepatitis B	0.00538	0.0056	CcSEcCtD
Loratadine—Syncope—Lamivudine—hepatitis B	0.00535	0.00557	CcSEcCtD
Loratadine—Loss of consciousness—Lamivudine—hepatitis B	0.00525	0.00546	CcSEcCtD
Loratadine—Cough—Lamivudine—hepatitis B	0.00521	0.00542	CcSEcCtD
Loratadine—Nausea—Telbivudine—hepatitis B	0.00514	0.00535	CcSEcCtD
Loratadine—Myalgia—Lamivudine—hepatitis B	0.00508	0.00529	CcSEcCtD
Loratadine—Chest pain—Lamivudine—hepatitis B	0.00508	0.00529	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00505	0.00525	CcSEcCtD
Loratadine—Discomfort—Lamivudine—hepatitis B	0.00502	0.00523	CcSEcCtD
Loratadine—Dry mouth—Lamivudine—hepatitis B	0.00497	0.00517	CcSEcCtD
Loratadine—Anaphylactic shock—Lamivudine—hepatitis B	0.00487	0.00507	CcSEcCtD
Loratadine—Shock—Lamivudine—hepatitis B	0.00479	0.00499	CcSEcCtD
Loratadine—Nervous system disorder—Lamivudine—hepatitis B	0.00478	0.00497	CcSEcCtD
Loratadine—Skin disorder—Lamivudine—hepatitis B	0.00473	0.00493	CcSEcCtD
Loratadine—Hypotension—Lamivudine—hepatitis B	0.00455	0.00474	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00444	0.00462	CcSEcCtD
Loratadine—Insomnia—Lamivudine—hepatitis B	0.00441	0.00459	CcSEcCtD
Loratadine—Paraesthesia—Lamivudine—hepatitis B	0.00437	0.00455	CcSEcCtD
Loratadine—Somnolence—Lamivudine—hepatitis B	0.00433	0.00451	CcSEcCtD
Loratadine—Dyspepsia—Lamivudine—hepatitis B	0.00429	0.00446	CcSEcCtD
Loratadine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00421	0.00438	CcSEcCtD
Loratadine—Fatigue—Lamivudine—hepatitis B	0.0042	0.00437	CcSEcCtD
Loratadine—Pain—Lamivudine—hepatitis B	0.00417	0.00434	CcSEcCtD
Loratadine—Constipation—Lamivudine—hepatitis B	0.00417	0.00434	CcSEcCtD
Loratadine—Feeling abnormal—Lamivudine—hepatitis B	0.00401	0.00418	CcSEcCtD
Loratadine—Gastrointestinal pain—Lamivudine—hepatitis B	0.00398	0.00415	CcSEcCtD
Loratadine—Body temperature increased—Lamivudine—hepatitis B	0.00385	0.00401	CcSEcCtD
Loratadine—Abdominal pain—Lamivudine—hepatitis B	0.00385	0.00401	CcSEcCtD
Loratadine—Asthenia—Lamivudine—hepatitis B	0.0035	0.00364	CcSEcCtD
Loratadine—Diarrhoea—Lamivudine—hepatitis B	0.00333	0.00347	CcSEcCtD
Loratadine—Dizziness—Lamivudine—hepatitis B	0.00322	0.00335	CcSEcCtD
Loratadine—Vomiting—Lamivudine—hepatitis B	0.0031	0.00322	CcSEcCtD
Loratadine—Rash—Lamivudine—hepatitis B	0.00307	0.0032	CcSEcCtD
Loratadine—Dermatitis—Lamivudine—hepatitis B	0.00307	0.00319	CcSEcCtD
Loratadine—Headache—Lamivudine—hepatitis B	0.00305	0.00318	CcSEcCtD
Loratadine—Nausea—Lamivudine—hepatitis B	0.00289	0.00301	CcSEcCtD
Loratadine—KCNH2—Voltage gated Potassium channels—KCNH1—hepatitis B	0.00289	0.0735	CbGpPWpGaD
Loratadine—KCNH2—Potassium Channels—KCNH1—hepatitis B	0.00148	0.0377	CbGpPWpGaD
Loratadine—CYP2C8—CYP2E1 reactions—CYP2A6—hepatitis B	0.00148	0.0377	CbGpPWpGaD
Loratadine—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.00132	0.0336	CbGpPWpGaD
Loratadine—CYP2D6—CYP2E1 reactions—CYP2A6—hepatitis B	0.00122	0.0309	CbGpPWpGaD
Loratadine—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00121	0.0307	CbGpPWpGaD
Loratadine—CYP2C8—Xenobiotics—CYP2A6—hepatitis B	0.00092	0.0233	CbGpPWpGaD
Loratadine—CYP2D6—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.000902	0.0229	CbGpPWpGaD
Loratadine—CYP2C8—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000884	0.0225	CbGpPWpGaD
Loratadine—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.000849	0.0215	CbGpPWpGaD
Loratadine—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.000821	0.0208	CbGpPWpGaD
Loratadine—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000789	0.02	CbGpPWpGaD
Loratadine—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.000789	0.02	CbGpPWpGaD
Loratadine—CYP2D6—Xenobiotics—CYP2A6—hepatitis B	0.000755	0.0192	CbGpPWpGaD
Loratadine—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.000748	0.019	CbGpPWpGaD
Loratadine—CYP2D6—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000726	0.0184	CbGpPWpGaD
Loratadine—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00072	0.0183	CbGpPWpGaD
Loratadine—KCNH2—Neuronal System—KCNH1—hepatitis B	0.000648	0.0165	CbGpPWpGaD
Loratadine—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00059	0.015	CbGpPWpGaD
Loratadine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000564	0.0143	CbGpPWpGaD
Loratadine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00055	0.014	CbGpPWpGaD
Loratadine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000514	0.013	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.000508	0.0129	CbGpPWpGaD
Loratadine—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000494	0.0125	CbGpPWpGaD
Loratadine—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000475	0.0121	CbGpPWpGaD
Loratadine—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000401	0.0102	CbGpPWpGaD
Loratadine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000382	0.00969	CbGpPWpGaD
Loratadine—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000377	0.00957	CbGpPWpGaD
Loratadine—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.000345	0.00876	CbGpPWpGaD
Loratadine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000341	0.00865	CbGpPWpGaD
Loratadine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000339	0.0086	CbGpPWpGaD
Loratadine—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000336	0.00854	CbGpPWpGaD
Loratadine—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000328	0.00832	CbGpPWpGaD
Loratadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000313	0.00796	CbGpPWpGaD
Loratadine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000311	0.00789	CbGpPWpGaD
Loratadine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00031	0.00786	CbGpPWpGaD
Loratadine—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000309	0.00785	CbGpPWpGaD
Loratadine—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000308	0.00782	CbGpPWpGaD
Loratadine—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000307	0.00779	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000293	0.00743	CbGpPWpGaD
Loratadine—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000281	0.00713	CbGpPWpGaD
Loratadine—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.000279	0.00709	CbGpPWpGaD
Loratadine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000276	0.00701	CbGpPWpGaD
Loratadine—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.000271	0.00689	CbGpPWpGaD
Loratadine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—hepatitis B	0.000267	0.00678	CbGpPWpGaD
Loratadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000254	0.00645	CbGpPWpGaD
Loratadine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000252	0.0064	CbGpPWpGaD
Loratadine—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000249	0.00633	CbGpPWpGaD
Loratadine—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000242	0.00615	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000233	0.00592	CbGpPWpGaD
Loratadine—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000229	0.00582	CbGpPWpGaD
Loratadine—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000227	0.00577	CbGpPWpGaD
Loratadine—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000223	0.00566	CbGpPWpGaD
Loratadine—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000221	0.00561	CbGpPWpGaD
Loratadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000205	0.0052	CbGpPWpGaD
Loratadine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000202	0.00514	CbGpPWpGaD
Loratadine—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000192	0.00488	CbGpPWpGaD
Loratadine—HRH1—IL-4 Signaling Pathway—NFKB1—hepatitis B	0.000181	0.0046	CbGpPWpGaD
Loratadine—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000177	0.00449	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000172	0.00437	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000172	0.00437	CbGpPWpGaD
Loratadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000166	0.00422	CbGpPWpGaD
Loratadine—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000164	0.00417	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.00016	0.00406	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000154	0.00392	CbGpPWpGaD
Loratadine—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000152	0.00387	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000152	0.00385	CbGpPWpGaD
Loratadine—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.00015	0.0038	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000148	0.00375	CbGpPWpGaD
Loratadine—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000147	0.00373	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000146	0.0037	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000143	0.00364	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.00014	0.00356	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000139	0.00352	CbGpPWpGaD
Loratadine—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000135	0.00343	CbGpPWpGaD
Loratadine—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000134	0.0034	CbGpPWpGaD
Loratadine—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000128	0.00326	CbGpPWpGaD
Loratadine—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000115	0.00291	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000111	0.00283	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000109	0.00276	CbGpPWpGaD
Loratadine—HRH1—G alpha (q) signalling events—F2—hepatitis B	0.000106	0.0027	CbGpPWpGaD
Loratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000106	0.00269	CbGpPWpGaD
Loratadine—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000105	0.00268	CbGpPWpGaD
Loratadine—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000104	0.00265	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.000101	0.00257	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	9.7e-05	0.00246	CbGpPWpGaD
Loratadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	9.57e-05	0.00243	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	9.5e-05	0.00241	CbGpPWpGaD
Loratadine—KCNH2—SIDS Susceptibility Pathways—IL6—hepatitis B	8.99e-05	0.00228	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—IL2—hepatitis B	8.99e-05	0.00228	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	8.85e-05	0.00225	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	8.83e-05	0.00224	CbGpPWpGaD
Loratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	8.2e-05	0.00208	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—CXCL10—hepatitis B	8.05e-05	0.00204	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	7.89e-05	0.002	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	7.61e-05	0.00193	CbGpPWpGaD
Loratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	7.04e-05	0.00179	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—TGFB1—hepatitis B	7.01e-05	0.00178	CbGpPWpGaD
Loratadine—CYP3A4—Biological oxidations—GGT1—hepatitis B	6.89e-05	0.00175	CbGpPWpGaD
Loratadine—ABCB1—Allograft Rejection—TNF—hepatitis B	6.55e-05	0.00166	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—CCR5—hepatitis B	6.25e-05	0.00159	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SAG—hepatitis B	6.19e-05	0.00157	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RIT2—hepatitis B	6.19e-05	0.00157	CbGpPWpGaD
Loratadine—HRH1—GPCR ligand binding—F2—hepatitis B	5.36e-05	0.00136	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.93e-05	0.00125	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKR1B1—hepatitis B	4.84e-05	0.00123	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GGT2—hepatitis B	4.64e-05	0.00118	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—CXCL10—hepatitis B	4.55e-05	0.00116	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.4e-05	0.00112	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKR1B1—hepatitis B	4.32e-05	0.0011	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	4.28e-05	0.00109	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKR1B1—hepatitis B	4.22e-05	0.00107	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	4.18e-05	0.00106	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	4.17e-05	0.00106	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	4.15e-05	0.00105	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GGT2—hepatitis B	4.14e-05	0.00105	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CXCL10—hepatitis B	4.13e-05	0.00105	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GGT2—hepatitis B	4.04e-05	0.00103	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.01e-05	0.00102	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKR1B1—hepatitis B	3.97e-05	0.00101	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKR1B1—hepatitis B	3.94e-05	0.001	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GGT2—hepatitis B	3.81e-05	0.000967	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GGT2—hepatitis B	3.78e-05	0.000959	CbGpPWpGaD
Loratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	3.76e-05	0.000955	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—CCR5—hepatitis B	3.53e-05	0.000896	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	3.46e-05	0.000878	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	3.23e-05	0.00082	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CCR5—hepatitis B	3.21e-05	0.000814	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—F2—hepatitis B	3.03e-05	0.000769	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.85e-05	0.000723	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP2A6—hepatitis B	2.81e-05	0.000714	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—F2—hepatitis B	2.75e-05	0.000698	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.62e-05	0.000666	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.6e-05	0.00066	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GOT2—hepatitis B	2.54e-05	0.000646	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2A6—hepatitis B	2.51e-05	0.000637	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GGT2—hepatitis B	2.49e-05	0.000632	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2A6—hepatitis B	2.45e-05	0.000622	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL10—hepatitis B	2.44e-05	0.00062	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.34e-05	0.000594	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2A6—hepatitis B	2.31e-05	0.000586	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2A6—hepatitis B	2.29e-05	0.000581	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GOT2—hepatitis B	2.27e-05	0.000576	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GOT2—hepatitis B	2.22e-05	0.000562	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GOT1—hepatitis B	2.2e-05	0.000557	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GGT1—hepatitis B	2.2e-05	0.000557	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	2.17e-05	0.000551	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.13e-05	0.000542	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GOT2—hepatitis B	2.09e-05	0.00053	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GOT2—hepatitis B	2.07e-05	0.000525	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—IL2—hepatitis B	2.04e-05	0.000518	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2e-05	0.000508	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GOT1—hepatitis B	1.96e-05	0.000497	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GGT1—hepatitis B	1.96e-05	0.000497	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GOT1—hepatitis B	1.91e-05	0.000486	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GGT1—hepatitis B	1.91e-05	0.000486	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCR5—hepatitis B	1.89e-05	0.000481	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL2—hepatitis B	1.85e-05	0.00047	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GGT1—hepatitis B	1.8e-05	0.000458	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GOT1—hepatitis B	1.8e-05	0.000458	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GOT1—hepatitis B	1.79e-05	0.000454	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GGT1—hepatitis B	1.79e-05	0.000454	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.79e-05	0.000453	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.63e-05	0.000413	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—F2—hepatitis B	1.62e-05	0.000412	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.51e-05	0.000383	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GOT2—hepatitis B	1.37e-05	0.000347	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GOT1—hepatitis B	1.18e-05	0.000299	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GGT1—hepatitis B	1.18e-05	0.000299	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALB—hepatitis B	1.17e-05	0.000296	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2—hepatitis B	1.09e-05	0.000278	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—hepatitis B	1.09e-05	0.000276	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CTNNB1—hepatitis B	1.06e-05	0.000268	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALB—hepatitis B	1.04e-05	0.000265	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1A—hepatitis B	1.03e-05	0.000262	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTEN—hepatitis B	1.03e-05	0.000261	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NFKB1—hepatitis B	1.02e-05	0.00026	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALB—hepatitis B	1.02e-05	0.000258	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALB—hepatitis B	9.59e-06	0.000243	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALB—hepatitis B	9.5e-06	0.000241	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTEN—hepatitis B	8.91e-06	0.000226	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TGFB1—hepatitis B	8.53e-06	0.000217	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTEN—hepatitis B	7.95e-06	0.000202	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTEN—hepatitis B	7.76e-06	0.000197	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTEN—hepatitis B	7.31e-06	0.000186	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTEN—hepatitis B	7.25e-06	0.000184	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—hepatitis B	7.03e-06	0.000178	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—hepatitis B	6.43e-06	0.000163	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALB—hepatitis B	6.27e-06	0.000159	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTEN—hepatitis B	4.78e-06	0.000121	CbGpPWpGaD
